202 related articles for article (PubMed ID: 8986758)
21. Mutational analysis of the interaction between CD4 and class II MHC: class II antigens contact CD4 on a surface opposite the gp120-binding site.
Fleury S; Lamarre D; Meloche S; Ryu SE; Cantin C; Hendrickson WA; Sekaly RP
Cell; 1991 Sep; 66(5):1037-49. PubMed ID: 1889086
[TBL] [Abstract][Full Text] [Related]
22. An efficient phage plaque screen for the random mutational analysis of the interaction of HIV-1 gp120 with human CD4.
Tsui P; Sweet RW; Sathe G; Rosenberg M
J Biol Chem; 1992 May; 267(13):9361-7. PubMed ID: 1533631
[TBL] [Abstract][Full Text] [Related]
23. The C4 region as a target for HIV entry inhibitors--NMR mapping of the interacting segments of T20 and gp120.
Moseri A; Biron Z; Arshava B; Scherf T; Naider F; Anglister J
FEBS J; 2015 Dec; 282(24):4643-57. PubMed ID: 26432362
[TBL] [Abstract][Full Text] [Related]
24. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I
Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516
[TBL] [Abstract][Full Text] [Related]
25. Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120.
Turner S; Tizard R; DeMarinis J; Pepinsky RB; Zullo J; Schooley R; Fisher R
Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1335-9. PubMed ID: 1741386
[TBL] [Abstract][Full Text] [Related]
26. The glycan-mediated mechanism on the interactions of gp120 with CD4 and antibody: Insights from molecular dynamics simulation.
Zhang Y; Niu Y; Tian J; Liu X; Yao X; Liu H
Chem Biol Drug Des; 2017 Dec; 90(6):1237-1246. PubMed ID: 28632942
[TBL] [Abstract][Full Text] [Related]
27. Investigation of the structural components governing the polarity-dependent refolding of a CD4-binding peptide from gp120.
Graf von Stosch A; Kinzel V; Pipkorn R; Reed J
J Mol Biol; 1995 Jul; 250(4):507-13. PubMed ID: 7616571
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the site in CD4 that binds to the HIV envelope glycoprotein.
Brodsky MH; Warton M; Myers RM; Littman DR
J Immunol; 1990 Apr; 144(8):3078-86. PubMed ID: 1691226
[TBL] [Abstract][Full Text] [Related]
29. Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein.
Hoffman TL; LaBranche CC; Zhang W; Canziani G; Robinson J; Chaiken I; Hoxie JA; Doms RW
Proc Natl Acad Sci U S A; 1999 May; 96(11):6359-64. PubMed ID: 10339592
[TBL] [Abstract][Full Text] [Related]
30. Rational engineering of a miniprotein that reproduces the core of the CD4 site interacting with HIV-1 envelope glycoprotein.
Vita C; Drakopoulou E; Vizzavona J; Rochette S; Martin L; Ménez A; Roumestand C; Yang YS; Ylisastigui L; Benjouad A; Gluckman JC
Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13091-6. PubMed ID: 10557278
[TBL] [Abstract][Full Text] [Related]
31. CD4 peptide-protein conjugates, but not recombinant human CD4, bind to recombinant gp120 from the human immunodeficiency virus in the presence of serum from AIDS patients.
Ghetie V; Slaughter C; Wheeler HT; Uhr JW; Vitetta ES
Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5690-3. PubMed ID: 2062847
[TBL] [Abstract][Full Text] [Related]
32. Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120.
Sakihama T; Smolyar A; Reinherz EL
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6444-8. PubMed ID: 7604010
[TBL] [Abstract][Full Text] [Related]
33. High-affinity binding of southern African HIV type 1 subtype C envelope protein, gp120, to the CCR5 coreceptor.
Fromme BJ; Coetsee M; Van Der Watt P; Chan MC; Sperling KM; Katz AA; Flanagan CA
AIDS Res Hum Retroviruses; 2008 Dec; 24(12):1527-36. PubMed ID: 19018669
[TBL] [Abstract][Full Text] [Related]
34. Highly conserved beta16/beta17 beta-hairpin structure in human immunodeficiency virus type 1 YU2 gp120 is critical for CCR5 binding.
Mechulam A; Cerutti M; Pugnière M; Missé D; Gajardo J; Roquet F; Robinson J; Veas F
J Mol Med (Berl); 2005 Jul; 83(7):542-52. PubMed ID: 15905975
[TBL] [Abstract][Full Text] [Related]
35. Molecular dynamics simulations reveal distinct differences in conformational dynamics and thermodynamics between the unliganded and CD4-bound states of HIV-1 gp120.
Li Y; Deng L; Liang J; Dong GH; Xia YL; Fu YX; Liu SQ
Phys Chem Chem Phys; 2020 Mar; 22(10):5548-5560. PubMed ID: 32119016
[TBL] [Abstract][Full Text] [Related]
36. CD4-binding regions of human immunodeficiency virus envelope glycoprotein gp120 defined by proteolytic digestion.
Pollard SR; Meier W; Chow P; Rosa JJ; Wiley DC
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11320-4. PubMed ID: 1763044
[TBL] [Abstract][Full Text] [Related]
37. Enhanced dynamics of HIV gp120 glycoprotein by small molecule binding.
Shrivastava I; LaLonde JM
Biochemistry; 2011 May; 50(19):4173-83. PubMed ID: 21488663
[TBL] [Abstract][Full Text] [Related]
38. Thermodynamics of binding of a low-molecular-weight CD4 mimetic to HIV-1 gp120.
Schön A; Madani N; Klein JC; Hubicki A; Ng D; Yang X; Smith AB; Sodroski J; Freire E
Biochemistry; 2006 Sep; 45(36):10973-80. PubMed ID: 16953583
[TBL] [Abstract][Full Text] [Related]
39. Disulfide reduction in CD4 domain 1 or 2 is essential for interaction with HIV glycoprotein 120 (gp120), which impairs thioredoxin-driven CD4 dimerization.
Cerutti N; Killick M; Jugnarain V; Papathanasopoulos M; Capovilla A
J Biol Chem; 2014 Apr; 289(15):10455-10465. PubMed ID: 24550395
[TBL] [Abstract][Full Text] [Related]
40. CD4-affinity purification of recombinant and native HIV gp120 and comparison of the affinity constants for the receptor.
Moritz D; Dirckx L; Mous J; Schneider J
FEBS Lett; 1990 Nov; 275(1-2):146-50. PubMed ID: 2261984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
